surgical patient positioning News
-
Microlyte SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection
Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective clinical evaluation of its next-generation wound Matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and ankle surgery who would ordinarily be at risk of a surgical site infection. Results will be published in the October ...
-
DePuy Synthes Further Reimagines Knee Restoration with the Addition of Two New Innovations to the ATTUNE™ Knee Portfolio
Today, Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, is adding two new innovations to its kinematically advanced and proveni,ii,iii,iv,v,vi ATTUNE™ Knee portfolio: the ATTUNE™ Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology and the ATTUNE™ Medial Stabilized Knee System. Approximately 20 ...
-
With Policy Support, the Market for Surgical Robots Grows
Recently, the Ministry of Industry and Information Technology, the National Health Commission and other 17 departments jointly issued the "robot" application action implementation plan to encourage the development of surgery, auxiliary examination, auxiliary rounds, intensive care, rehabilitation and other medical robot products, "robot The "robot" has ushered in a new round of development ...
-
CMO & Co-founder Dr. Samuel Browd featured in Orthopedic Design & Technology
Proprio’s Chief Medical Officer & Co-founder, Dr. Samuel Browd, has been featured in industry-leading publication, Orthopedic Design & Technology. “Radically Improving Medicine & Surgery with Light Field Technology” emphasizes the opportunity to positively disrupt operating room technologies through light field and data intelligence for transforming surgical ...
-
BioStable Surpasses 500 Patients Treated Worldwide with the HAART Devices
BioStable Science & Engineering, Inc., a medical technology company focused on products for aortic valve repair for the treatment of aortic insufficiency, today announced that over 500 patients worldwide have now been treated using the HAART Aortic Annuloplasty Device. “Many cardiothoracic surgeons recognize that the young aortic insufficiency patient population cannot be treated with ...
-
Excite Medical displays the DRX9000 at the Wave 2019
Excite Medical, the leading provider of non-surgical spinal decompression machines, announced that they will participate in the upcoming WAVE Convention and Expo held at the Oakland Marriot City Center in Oakland, CA starting on August 16th. As an exhibitor, Excite Medical will present their flagship product, the DRX9000® non-surgical spinal decompression machine in front of over 2000 ...
-
SeaSpine Announces CE Mark Certification of 7D Surgical Cranial Module and Percutaneous Spine Module for Minimally Invasive Spine Surgery
CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it received simultaneous CE Mark certification for its Cranial Module and Percutaneous Spine Module for the 7D FLASH™ Navigation System. This achievement expands the ...
By 7D Surgical
-
Augmedics Begins First-in-Human Clinical Trial of xvision-spine (XVS) Augmented-Reality Surgical Navigation System
Augmedics has begun a first-in-human clinical trial of its xvision-spine (XVS) augmented-reality surgical navigation system at Sheba Tel Hashomer Medical Center and Asaf Harofeh Medical Center, in Israel. Led by Co-Principal Investigators Dr. Ran Harel and Prof. Yigal Mirovsky, the open label, prospective, single arm, multi-center study will evaluate the safety, performance, accuracy and ...
By Augmedics
-
ReShape Medical, Inc. Completes $38 Million Series D Financing
ReShape Medical® today announced that it has completed a Series D financing of $38 million led by HealthCor Partners Management, L.P. with participation from Endeavour Vision SA and existing investors, SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners and Venture Investors. The announcement follows the recent approval of the ReShape™ Integrated Dual Balloon System, a ...
-
Augmedics Announces FDA 510K Clearance and U.S. Launch of xvision, the First Augmented Reality Guidance System for Surgery
Augmedics, a pioneer in augmented reality surgical image guidance, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the U.S. launch of its groundbreaking xvision Spine system (XVS), the first AR guidance system to be used in surgery. xvision Spine allows surgeons to visualize the 3D spinal anatomy of a patient during surgery as if they had “x-ray vision,” and ...
By Augmedics
-
First Augmented Reality Spine Surgery Using FDA-Cleared Augmedics xvision Spine System Completed in U.S.
Augmedics, a pioneer in augmented reality surgical image guidance, has announced its groundbreaking xvision Spine System has been successfully used for the first time in a spinal fusion surgery in the United States. The system was used in a spinal surgery procedure by Johns Hopkins University surgeons. xvision, the first Augmented Reality Guidance system for surgery, allows surgeons to visualize ...
By Augmedics
-
Dr. Frank Phillips is First in the World to Use Augmented Reality Surgical Guidance in Minimally Invasive Spine Surgery
CHICAGO--(BUSINESS WIRE)--Midwest Orthopaedics at Rush announced today that Dr. Frank Phillips, Professor and Director of the Division of Spine Surgery and the Section of Minimally Invasive Spine Surgery at Rush University Medical Center, completed the first augmented reality (AR) minimally invasive spine surgery. The Augmedics xvision™ Spine System surgical guidance system allows a surgeon ...
By Augmedics
-
First Augmented Reality Spine Surgery Using FDA-Cleared Augmedics xvision Spine System Completed in U.S.
Augmedics, a pioneer in augmented reality surgical image guidance, has announced its groundbreaking xvision Spine System has been successfully used for the first time in a spinal fusion surgery in the United States. The system was used in a spinal surgery procedure by Johns Hopkins University surgeons. xvision, the first Augmented Reality Guidance system for surgery, allows surgeons to visualize ...
By Augmedics
-
Dr. James Lynch is the First US Private Practice Surgeon to Use Augmented Reality Spine Surgical Guidance at a Community Hospital
RENO, Nev., July 1, 2020 /PRNewswire/ — Spine Nevada Minimally Invasive Spine Institute announced that Dr. James Lynch, a board-certified and fellowship-trained neurological surgeon, was the first private practice surgeon in the United States to use the Augmedics xvision Spine System at a community hospital. xvision is the first Augmented Reality Guidance system to be used in surgery. It ...
By Augmedics
-
Pinnacle Spine Group Announces Launch of InFill V2 Lateral Interbody Device for Lumbar Spinal Fusion Surgeries
Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions engineered to deliver optimal bone graft volume and graft-to-endplate contact, today announced the launch of its InFill® V2 Lateral Interbody Device. The innovative InFill V2 Lateral Interbody Fusion device features a larger, single graft chamber and a large load-bearing surface area, which helps restore and maintain ...
-
Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Therapeutic Goods Administration (TGA) has approved its Carillon Mitral Contour System®. The Carillon System is a right heart transcatheter mitral valve repair (TMVr) device designed to treat the ...
-
PROCEPT Announces 5-Year WATER Study Data Comparing Aquablation to TURP
REDWOOD CITY, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced positive five-year results from its 181 patient randomized WATER study comparing Aquablation therapy to TURP, the historical standard of care for treating BPH. WATER ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you